Gaurang Brahmbhatt, MD
Family Medicine · Hoboken, NJNPI 1225204266
Payments from drug & device makers
Across 456 payments — averaging $5799.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$1.5M
- GSK$580K
- Adaptive Biotechnologies Corporation$225K
- Genentech, Inc.$94K
- Visby Medical, Inc.$59K
- Gilead$51K
- plus $132K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 67 | $1,504,200 |
| GSK | 30 | $580,353 |
| Adaptive Biotechnologies Corporation | 5 | $225,350 |
| Genentech, Inc. | 23 | $93,536 |
| Visby Medical, Inc. | 4 | $58,610 |
| Gilead | 161 | $50,934 |
| Amgen | 2 | $40,188 |
| Viiv Healthcare Company | 65 | $34,664 |
| Abbott | 2 | $26,686 |
| AstraZeneca | 4 | $16,418 |
| Vertex | 3 | $11,865 |
| Johnson & Johnson(2 entities) | 27 | $366 |
| Merck | 10 | $234 |
| Amarin Pharma, Inc. | 4 | $218 |
| Janssen Products, LP | 2 | $200 |
| Novo Nordisk | 5 | $118 |
| Napo Pharmaceuticals Inc | 8 | $107 |
| Daiichi Sankyo Inc. | 5 | $71 |
| Medtronic | 4 | $69 |
| Theratechnologies Inc. | 4 | $56 |
| Idorsia Pharmaceuticals US Inc | 3 | $45 |
| Dynavax Technologies Corporation | 3 | $35 |
| Pfizer | 2 | $28 |
| AbbVie | 2 | $28 |
| Genentech USA, Inc. | 2 | $25 |
| Exact Sciences | 1 | $21 |
| Welch Allyn | 1 | $19 |
| Phadia US Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| EMD Serono, Inc. | 1 | $13 |
How this compares
$2,644,546 in reported general payments places this provider in the 95th percentile of 2,084 family medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Hoboken
- Gregory TraceyHoboken$181K
- Juan LatorreHoboken$71K
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.